HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India

AIDS Research and Human Retroviruses

Volumn 21, Issue 4, 2005, Pages 301-305

  Balakrishnan, Pachamuthu ^a,e   Kumarasamy, Nagalingeswaran ^a   Kantor, Rami ^b   Solomon, Suniti ^a   Vidya, Sundararajan ^a   Mayer, Kenneth H ^c   Newstein, Michael ^c   Thyagarajan, Sadras P ^d   Katzenstein, David ^b   Ramratnam, Bharat ^c  

^a VHS Medical Centre India   (India)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF MADRAS   (India)

^e YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRANSCRIPTASE; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC VARIABILITY; GENOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; STRUCTURAL GENE; TREATMENT OUTCOME; WILD TYPE;

ADULT; AMINO ACID SUBSTITUTION; BASE SEQUENCE; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; INDIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; POLYMORPHISM, GENETIC; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

EID: 20944441738     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.301     Document Type: Article

References (15)

1. Kantor R, Zijenah LS, Shafer RW, et al.: HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy. AIDS Res Hum Retroviruses 2002;18:1407-1413.
2. Kumarasamy N, Solomon S, Chaguturu SK, et al.: The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India. AIDS 2003;17:2267-2269.
3. Boden D, Hurley A, Zhang L, et al.: HIV-1 drug resistance in newly infected individuals. JAMA 1999;282:1135-1141.
4. Little SJ, Holte S, Routy JP, et al.: Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002;347:385-394.
5. Weidle PJ, Downing R, Sozi C, et al.: Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative-Uganda. AIDS 2003;17(Suppl 3):S39-S48.
6. Kantor R, Katzenstein D, Gonzales MJ, et al.: Genotypic analyses of RT and protease sequences from persons infected with non-subtype B HIV-1. In: 10th Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts, 2003.
7. Gonzales MJ, Dugan JM, and Shafer RW: Synonymous-non-synonymous mutation rates between sequences containing ambiguous nucleotides (Syn-SCAN). Bioinformatics 2002;18:886-887.
8. Wu TD, Schiffer CA, Gonzales MJ, et al.: Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. J Virol 2003;77:4836-4847.
9. Gonzales MJ, Wu TD, Taylor J, et al.: Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors. AIDS 2003;17:791-799.
10. DeGruttola V, Dix L, D'Aquila R, et al.: The relation between baseline HIV drug resistance and response to antiretroviral therapy: Re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther 2000;5:41-48.
11. Hira SK, Panchal K, Parmar PA, et al.: High resistance to antiretroviral drugs: The Indian experience. Int J STD AIDS 2004;15:173-177.
12. Pieniazek D, Rayfield M, Hu DJ, et al.: Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group. AIDS 2000;14:1489-1495.
13. Cornelissen M, Van DB, Zorgdrager F, et al.: pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. J Virol 1997;71:6348-6358.
14. Becker-Pergola G, Kataaha P, Johnston-Dow L, et al.: Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults. AIDS Res Hum Retroviruses 2000;16:807-813.
15. Palmer S, Alaeus A, Albert J, et al.: Drug susceptibility of subtypes A, B, C, D, and E human immunodeficiency virus type 1 primary isolates. AIDS Res Hum Retroviruses 1998;14:157-162.